Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| 1 |
Intel
INTC
|
$581M |
| 2 |
Eli Lilly
LLY
|
$405M |
| 3 |
AbbVie
ABBV
|
$401M |
| 4 |
Adobe
ADBE
|
$395M |
| 5 |
Qualcomm
QCOM
|
$354M |
Top Sells
| 1 |
Linde
LIN
|
$1.47B |
| 2 |
Meta Platforms (Facebook)
META
|
$1.28B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$642M |
| 4 |
Tesla
TSLA
|
$570M |
| 5 |
Stellantis
STLA
|
$455M |
Sector Composition
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.88% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Financials | 10.29% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
XPeng
XPEV
$18.9B
| $11K | ﹤0.01% |
1,091
-674,050
| -100% | -$6.77M |
|
1877
ADT
ADT
$7.13B
| $10.3K | ﹤0.01% |
1,492
| – | – |
|
1878
Nu Skin
NUS
$569M
| $10.1K | ﹤0.01% |
+257
| New | +$10.1K |
|
1879
Adicet Bio
ACET
$60M
| $10.1K | ﹤0.01% |
1,836
| – | – |
|
1880
Cushman & Wakefield
CWK
$3.84B
| $10K | ﹤0.01% |
+1,015
| New | +$10K |
|
1881
iShares MSCI Europe Small-Cap ETF
IEUS
$153M
| $9.9K | ﹤0.01% |
188
| – | – |
|
1882
C4 Therapeutics
CCCC
$194M
| $9.19K | ﹤0.01% |
3,023
| – | – |
|
|
CANO
1883
DELISTED
Cano Health, Inc.
CANO
| $8.01K | ﹤0.01% |
61
| – | – |
|
1884
Petco
WOOF
$1.03B
| $7.52K | ﹤0.01% |
882
| – | – |
|
1885
Performance Food Group
PFGC
$16.5B
| $7.25K | ﹤0.01% |
121
+70
| +137% | +$4.2K |
|
1886
RBC Bearings
RBC
$12.2B
| $5.9K | ﹤0.01% |
27
+12
| +80% | +$2.62K |
|
1887
iShares S&P 500 Growth ETF
IVW
$63.7B
| $5.37K | ﹤0.01% |
84
-4,799
| -98% | -$307K |
|
1888
Reinsurance Group of America
RGA
$12.8B
| $5.27K | ﹤0.01% |
39
| – | – |
|
1889
XP
XP
$9.96B
| $5.17K | ﹤0.01% |
470
-4,113
| -90% | -$45.2K |
|
1890
SPDR Gold Trust
GLD
$112B
| $4.7K | ﹤0.01% |
25
-1,200
| -98% | -$225K |
|
1891
AptarGroup
ATR
$9.13B
| $4.64K | ﹤0.01% |
39
| – | – |
|
1892
OGE Energy
OGE
$8.89B
| $4.6K | ﹤0.01% |
118
| – | – |
|
1893
Invesco Energy Exploration & Production ETF
PXE
$70.5M
| $4.22K | ﹤0.01% |
151
-4,500
| -97% | -$126K |
|
1894
Casey's General Stores
CASY
$18.8B
| $4.08K | ﹤0.01% |
19
| – | – |
|
1895
Pacific Biosciences
PACB
$381M
| $3.99K | ﹤0.01% |
364
-9,035
| -96% | -$99K |
|
1896
Antero Resources
AR
$10.1B
| $3.94K | ﹤0.01% |
164
| – | – |
|
1897
Jones Lang LaSalle
JLL
$14.8B
| $3.87K | ﹤0.01% |
28
-89
| -76% | -$12.3K |
|
|
DCBO
1898
Docebo
DCBO
$896M
| $3.78K | ﹤0.01% |
100
| – | – |
|
1899
Unum
UNM
$12.6B
| $3.77K | ﹤0.01% |
96
| – | – |
|
1900
Mattel
MAT
$6.06B
| $3.72K | ﹤0.01% |
211
| – | – |
|